HEPATITIS C
Clinical trials for HEPATITIS C explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C trials appear
Sign up with your email to follow new studies for HEPATITIS C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hepatitis c drug shows promise in small trial
Disease control CompletedThis study tested whether a drug called MP-424 could help people with a specific type of chronic hepatitis C. Fifteen patients with genotype 1b hepatitis C who hadn't taken certain other medications received the treatment. Researchers checked if the virus remained undetectable si…
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 01, 2026 22:41 UTC
-
New drug combo aims to wipe out hepatitis c virus
Disease control CompletedThis study tested whether a combination of two oral drugs, bemnifosbuvir and ruzasvir, could safely and effectively treat chronic hepatitis C virus (HCV) infection. It involved 275 adults with HCV who had never taken this type of antiviral medication before. The main goal was to …
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New triple therapy tested against hepatitis c
Disease control CompletedThis completed Phase 3 trial tested whether adding an experimental drug (MP-424) to two standard hepatitis C medications could better control the virus. It involved 189 adults with a specific strain of hepatitis C who had never received treatment before. The main goal was to see …
Matched conditions: HEPATITIS C
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo tested for hepatitis c patients who failed prior treatment
Disease control CompletedThis study tested whether adding an experimental drug called MP-424 to two standard Hepatitis C medications could help patients whose previous treatments didn't work. It involved 32 adults with a specific type of Hepatitis C (Genotype 1) who had not responded to earlier therapy. …
Matched conditions: HEPATITIS C
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test for new hepatitis c treatment begins
Disease control CompletedThis early-stage study tested the safety of a new drug called MP-424 when given alongside two standard hepatitis C medications. It involved 20 patients with a specific type of chronic hepatitis C. The main goal was to see how the body processes the new drug and to check for any s…
Matched conditions: HEPATITIS C
Phase: PHASE1 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New program aims to bridge healthcare gap for people leaving prison
Disease control CompletedThis study tested a new support program designed to help people with HIV, hepatitis C, or substance use disorders get medical care after they are released from prison. Researchers worked with 219 men and women before their release to see if the program was practical and acceptabl…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can a smartphone app help prevent HIV after jail release?
Prevention CompletedThis study tested whether a smartphone app called GeoPassport, combined with peer mentor support and small rewards, could help men and transgender women leaving jail access important health services. The goal was to see if this approach helped people get HIV prevention medication…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Mar 30, 2026 14:34 UTC
-
Hidden infections: rapid tests reveal disease burden in detention
Knowledge-focused CompletedThis study aimed to find out how many people held in a specific French detention center had HIV, hepatitis B, or hepatitis C. Researchers used rapid tests to screen 350 detainees, as many come from regions where these infections are common and may not know their status. The goal …
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Scientists hunt for hepatitis C's hidden helpers
Knowledge-focused CompletedThis study aimed to better understand how the hepatitis C virus (HCV) works by identifying human proteins that stick to the virus particles. Researchers analyzed blood samples from 10 people with chronic HCV to see which human proteins the virus carries with it. The goal was to f…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC
-
Scientists track silent hepatitis in blood donors
Knowledge-focused CompletedThis study aimed to learn more about Hepatitis C virus (HCV) infection in people who donated blood. Researchers followed over 800 blood donors who tested positive for HCV antibodies to understand how the virus spreads, who remains infected, and what liver problems might develop. …
Matched conditions: HEPATITIS C
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC